Annual Total Liabilities
$4.57 B
-$2.16 B-32.12%
31 December 2023
Summary:
Moderna annual total liabilities is currently $4.57 billion, with the most recent change of -$2.16 billion (-32.12%) on 31 December 2023. During the last 3 years, it has fallen by -$5.95 billion (-56.56%). MRNA annual total liabilities is now -56.56% below its all-time high of $10.52 billion, reached on 31 December 2021.MRNA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$3.88 B
-$92.00 M-2.32%
30 September 2024
Summary:
Moderna quarterly total liabilities is currently $3.88 billion, with the most recent change of -$92.00 million (-2.32%) on 30 September 2024. Over the past year, it has dropped by -$696.00 million (-15.22%). MRNA quarterly total liabilities is now -64.11% below its all-time high of $10.80 billion, reached on 30 September 2021.MRNA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRNA Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -15.2% |
| 3 y3 years | -56.6% | -63.2% |
| 5 y5 years | +1002.7% | +834.9% |
MRNA Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -56.6% | at low | -63.2% | at low |
| 5 y | 5 years | -56.6% | +1002.7% | -64.1% | +834.9% |
| alltime | all time | -56.6% | >+9999.0% | -64.1% | >+9999.0% |
Moderna Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.88 B(-2.3%) |
| June 2024 | - | $3.97 B(+1.4%) |
| Mar 2024 | - | $3.91 B(-14.4%) |
| Dec 2023 | $4.57 B(-32.1%) | $4.57 B(-23.7%) |
| Sept 2023 | - | $6.00 B(+21.5%) |
| June 2023 | - | $4.93 B(-6.2%) |
| Mar 2023 | - | $5.26 B(-21.9%) |
| Dec 2022 | $6.74 B(-36.0%) | $6.74 B(-16.5%) |
| Sept 2022 | - | $8.06 B(+0.1%) |
| June 2022 | - | $8.06 B(-23.5%) |
| Mar 2022 | - | $10.53 B(+0.1%) |
| Dec 2021 | $10.52 B(+120.4%) | $10.52 B(-2.5%) |
| Sept 2021 | - | $10.80 B(+14.3%) |
| June 2021 | - | $9.45 B(+6.7%) |
| Mar 2021 | - | $8.86 B(+85.4%) |
| Dec 2020 | $4.78 B(+1051.9%) | $4.78 B(+152.6%) |
| Sept 2020 | - | $1.89 B(+250.8%) |
| June 2020 | - | $539.12 M(+26.4%) |
| Mar 2020 | - | $426.67 M(+2.9%) |
| Dec 2019 | $414.61 M(-4.0%) | $414.61 M(+22.3%) |
| Sept 2019 | - | $339.09 M(-2.2%) |
| June 2019 | - | $346.73 M(-3.7%) |
| Mar 2019 | - | $360.17 M(-16.6%) |
| Dec 2018 | $431.91 M(-5.9%) | $431.91 M(+4.6%) |
| Sept 2018 | - | $412.73 M(-10.1%) |
| Dec 2017 | $459.19 M(-20.2%) | $459.19 M(+9851.1%) |
| Sept 2017 | - | $4.61 M(+11.0%) |
| June 2017 | - | $4.16 M(+54.1%) |
| Mar 2017 | - | $2.70 M(-9.1%) |
| Dec 2016 | $575.31 M(+7746.6%) | - |
| Dec 2016 | - | $2.97 M(-45.8%) |
| Sept 2016 | - | $5.48 M(-9.8%) |
| June 2016 | - | $6.07 M(+6.7%) |
| Mar 2016 | - | $5.69 M(-22.4%) |
| Dec 2015 | $7.33 M(-46.0%) | $7.33 M(-14.0%) |
| Sept 2015 | - | $8.52 M(-15.2%) |
| June 2015 | - | $10.05 M(-14.1%) |
| Mar 2015 | - | $11.70 M(-13.9%) |
| Dec 2014 | $13.59 M(-8.2%) | $13.59 M(-32.6%) |
| Sept 2014 | - | $20.14 M(+39.6%) |
| June 2014 | - | $14.43 M(-26.6%) |
| Mar 2014 | - | $19.65 M(+32.7%) |
| Dec 2013 | $14.81 M(+13.2%) | $14.81 M(+20.3%) |
| Sept 2013 | - | $12.31 M(+11.3%) |
| June 2013 | - | $11.06 M(-0.5%) |
| Mar 2013 | - | $11.12 M(-15.0%) |
| Dec 2012 | $13.08 M(+11.7%) | $13.08 M(+26.2%) |
| Sept 2012 | - | $10.36 M(-13.9%) |
| June 2012 | - | $12.04 M(-14.1%) |
| Mar 2012 | - | $14.02 M(+19.7%) |
| Dec 2011 | $11.71 M(-4.6%) | $11.71 M(-4.5%) |
| Sept 2011 | - | $12.26 M(-22.8%) |
| June 2011 | - | $15.89 M(+61.4%) |
| Mar 2011 | - | $9.84 M(-19.8%) |
| Dec 2010 | $12.27 M(-13.0%) | $12.27 M(-13.0%) |
| Sept 2010 | - | $14.12 M(-28.7%) |
| June 2010 | - | $19.81 M(+9.3%) |
| Mar 2010 | - | $18.12 M(+28.4%) |
| Dec 2009 | $14.12 M(-13.9%) | $14.12 M(-15.0%) |
| Sept 2009 | - | $16.61 M(-0.4%) |
| June 2009 | - | $16.69 M(+48.3%) |
| Mar 2009 | - | $11.26 M(-31.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2008 | $16.40 M(-26.8%) | $16.40 M(+2.9%) |
| Sept 2008 | - | $15.94 M(+0.1%) |
| June 2008 | - | $15.93 M(-17.7%) |
| Mar 2008 | - | $19.34 M(-13.6%) |
| Dec 2007 | $22.40 M(-26.6%) | $22.40 M(-21.9%) |
| Sept 2007 | - | $28.68 M(+1.5%) |
| June 2007 | - | $28.25 M(-1.8%) |
| Mar 2007 | - | $28.78 M(-5.6%) |
| Dec 2006 | $30.50 M(+75.4%) | $30.50 M(+16.6%) |
| Sept 2006 | - | $26.15 M(+12.0%) |
| June 2006 | - | $23.36 M(+6.8%) |
| Mar 2006 | - | $21.87 M(+25.8%) |
| Dec 2005 | $17.39 M(-23.2%) | $17.39 M(+14.1%) |
| Sept 2005 | - | $15.24 M(-6.2%) |
| June 2005 | - | $16.25 M(+12.3%) |
| Mar 2005 | - | $14.47 M(-36.0%) |
| Dec 2004 | $22.63 M(+71.0%) | $22.63 M(+9.2%) |
| Sept 2004 | - | $20.72 M(+33.6%) |
| June 2004 | - | $15.51 M(+4.4%) |
| Mar 2004 | - | $14.85 M(+12.2%) |
| Dec 2003 | $13.23 M(-8.1%) | $13.23 M(-2.6%) |
| Sept 2003 | - | $13.58 M(-2.4%) |
| June 2003 | - | $13.91 M(-44.5%) |
| Mar 2003 | - | $25.05 M(+73.9%) |
| Dec 2002 | $14.40 M(+640.2%) | $14.40 M(-2.9%) |
| Sept 2002 | - | $14.84 M(+90.4%) |
| June 2002 | - | $7.79 M(+44.0%) |
| Mar 2002 | - | $5.41 M(+178.1%) |
| Dec 2001 | $1.95 M(-7.2%) | $1.95 M(+8.6%) |
| Sept 2001 | - | $1.79 M(-4.0%) |
| June 2001 | - | $1.87 M(-15.1%) |
| Mar 2001 | - | $2.20 M(+4.8%) |
| Dec 2000 | $2.10 M(-41.8%) | $2.10 M(-12.2%) |
| Sept 2000 | - | $2.39 M(-0.0%) |
| June 2000 | - | $2.39 M(+26.2%) |
| Mar 2000 | - | $1.89 M(-47.4%) |
| Dec 1999 | $3.60 M(+80.0%) | $3.60 M(+38.4%) |
| Sept 1999 | - | $2.60 M(+30.0%) |
| June 1999 | - | $2.00 M(-13.0%) |
| Mar 1999 | - | $2.30 M(+15.0%) |
| Dec 1998 | $2.00 M(-20.0%) | $2.00 M(-4.8%) |
| Sept 1998 | - | $2.10 M(0.0%) |
| June 1998 | - | $2.10 M(+23.5%) |
| Mar 1998 | - | $1.70 M(-32.0%) |
| Dec 1997 | $2.50 M(+127.3%) | $2.50 M(+31.6%) |
| Sept 1997 | - | $1.90 M(+5.6%) |
| June 1997 | - | $1.80 M(+28.6%) |
| Mar 1997 | - | $1.40 M(+75.0%) |
| Dec 1996 | $1.10 M(-38.9%) | - |
| Sept 1996 | - | $800.00 K(-55.6%) |
| June 1996 | $1.80 M(0.0%) | $1.80 M(+20.0%) |
| Mar 1996 | - | $1.50 M(0.0%) |
| Dec 1995 | - | $1.50 M(-11.8%) |
| Sept 1995 | - | $1.70 M(-5.6%) |
| June 1995 | $1.80 M(+5.9%) | $1.80 M(+20.0%) |
| Mar 1995 | - | $1.50 M(+7.1%) |
| Dec 1994 | - | $1.40 M(-6.7%) |
| Sept 1994 | - | $1.50 M(-11.8%) |
| June 1994 | $1.70 M | $1.70 M(+13.3%) |
| Mar 1994 | - | $1.50 M(-6.3%) |
| Dec 1993 | - | $1.60 M(0.0%) |
| Sept 1993 | - | $1.60 M |
FAQ
- What is Moderna annual total liabilities?
- What is the all time high annual total liabilities for Moderna?
- What is Moderna quarterly total liabilities?
- What is the all time high quarterly total liabilities for Moderna?
- What is Moderna quarterly total liabilities year-on-year change?
What is Moderna annual total liabilities?
The current annual total liabilities of MRNA is $4.57 B
What is the all time high annual total liabilities for Moderna?
Moderna all-time high annual total liabilities is $10.52 B
What is Moderna quarterly total liabilities?
The current quarterly total liabilities of MRNA is $3.88 B
What is the all time high quarterly total liabilities for Moderna?
Moderna all-time high quarterly total liabilities is $10.80 B
What is Moderna quarterly total liabilities year-on-year change?
Over the past year, MRNA quarterly total liabilities has changed by -$696.00 M (-15.22%)